# Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

> **NCT01023269** · NA · TERMINATED · sponsor: **MedtronicNeuro** · enrollment: 17 (actual)

## Conditions studied

- Neurogenic Overactive Bladder
- Urinary Incontinence
- Detrusor Overactivity

## Interventions

- **DEVICE:** InterStim Therapy

## Key facts

- **NCT ID:** NCT01023269
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** difficulty in the enrolment
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023269, "Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01023269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*